{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=42", "query": { "intervention": "Blinded (placebo)", "page": 42 }, "page_size": 10 }, "pagination": { "page": 42, "page_size": 10, "total_count": 2208, "total_pages": 221, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=43&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blinded+%28placebo%29&page=41&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T21:23:14.737Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00394771", "title": "A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breakthrough Bleeding" ], "interventions": [ { "name": "DR-1031", "type": "DRUG" }, { "name": "Seasonale®", "type": "DRUG" }, { "name": "Portia®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duramed Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 567, "start_date": "2006-10", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2013-07-26", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 50, "location_summary": "Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 45 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00394771" }, { "nct_id": "NCT02901275", "title": "Enhancing Medication-based Analgesia in Humans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain", "Cannabis", "Opioid Use, Unspecified" ], "interventions": [ { "name": "Within-subject test of blinded study medications", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 29, "start_date": "2016-12", "completion_date": "2020-03-23", "has_results": true, "last_update_posted_date": "2023-11-07", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02901275" }, { "nct_id": "NCT04643067", "title": "Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "SLE; Drug" ], "interventions": [ { "name": "KPG-818 low dose in phase 1b", "type": "DRUG" }, { "name": "KPG-818 mid dose in phase 1b", "type": "DRUG" }, { "name": "KPG-818 high dose in phase 1b", "type": "DRUG" }, { "name": "KPG-818 ultra-high dose in phase 1b", "type": "DRUG" }, { "name": "KPG-818 low dose in phase 2a", "type": "DRUG" }, { "name": "KPG-818 mid dose in phase 2a", "type": "DRUG" }, { "name": "KPG-818 high dose in phase 2a", "type": "DRUG" }, { "name": "KPG-818 Placebo in phase 2a", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kangpu Biopharmaceuticals, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2021-06-03", "completion_date": "2023-06-29", "has_results": true, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 18, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Clearwater, Florida + 12 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Cutler Bay", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04643067" }, { "nct_id": "NCT07547436", "title": "A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-cystic Fibrosis Bronchiectasis" ], "interventions": [ { "name": "SAR445399", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 70, "start_date": "2026-06-08", "completion_date": "2029-05-11", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 4, "location_summary": "Phoenix, Arizona • Loxahatchee Groves, Florida • Plantation, Florida + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "Plantation", "state": "Florida" }, { "city": "DuBois", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07547436" }, { "nct_id": "NCT00635232", "title": "A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "irbesartan", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "PS433540", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ligand Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 261, "start_date": "2008-03", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2011-09-16", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 40, "location_summary": "Pell City, Alabama • Tempe, Arizona • Tucson, Arizona + 36 more", "locations": [ { "city": "Pell City", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Buena Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00635232" }, { "nct_id": "NCT05009498", "title": "Vitamin D3 Supplementation for Vitamin D Deficiency in Rotator Cuff Repair Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vitamin D Deficiency", "Rotator Cuff Tears" ], "interventions": [ { "name": "Vitamin D3 supplementation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Community Memorial Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 240, "start_date": "2021-09-01", "completion_date": "2024-08-01", "has_results": false, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 2, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" }, { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05009498" }, { "nct_id": "NCT00810758", "title": "Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C Virus" ], "interventions": [ { "name": "PF-04878691 3mg", "type": "DRUG" }, { "name": "PF-04878691 6mg", "type": "DRUG" }, { "name": "PF-04878691 9mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2009-01", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2009-12-01", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00810758" }, { "nct_id": "NCT01915849", "title": "Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "LIK066", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 14, "start_date": "2013-07", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2015-02-06", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01915849" }, { "nct_id": "NCT05160558", "title": "A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Spinocerebellar Ataxia Type 3" ], "interventions": [ { "name": "BIIB132", "type": "DRUG" }, { "name": "BIIB132-Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 8, "start_date": "2022-02-02", "completion_date": "2023-07-25", "has_results": false, "last_update_posted_date": "2023-08-04", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Gainesville, Florida + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05160558" }, { "nct_id": "NCT02052752", "title": "A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Skin Diseases" ], "interventions": [ { "name": "3% Benzoyl Peroxide", "type": "DRUG" }, { "name": "3% Benzoyl Peroxide Placebo", "type": "DRUG" }, { "name": "Neutrogena Rapid Clear®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 90, "start_date": "2014-02", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-05-18", "last_synced_at": "2026-10-16T21:23:14.737Z", "location_count": 1, "location_summary": "High Point, North Carolina", "locations": [ { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02052752" } ] }